SCHEMBL6809576

SCHEMBL6809576

COC(=O)[C@H](CO)NCC=Cc1cccc(Oc2ccccc2)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPOR P19235 8/20 0.55
ALOX5 P09917 3/20 0.54
PTGS1 P23219 2/20 0.54
PTGS2 P35354 2/20 0.54
ALOX5AP P20292 1/20 0.54
BACE1 P56817 1/20 0.49
KDM5A P29375 1/20 0.47
TLR4 O00206 1/20 0.43
TLR2 O60603 1/20 0.43
MAPT P10636 2/20 0.42
GRIK1 P39086 1/20 0.42
GRIK2 Q13002 1/20 0.42
ATM Q13315 1/20 0.42
ALDH1A1 P00352 1/20 0.42
LMNA P02545 1/20 0.42
BCHE P06276 1/20 0.41
MEN1 O00255 1/20 0.41
NPC1 O15118 1/20 0.41
POLB P06746 1/20 0.41
RAB9A P51151 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5498502 0.87 EPOR (0.59) EPORALOX5PTGS1PTGS2ALOX5AP
SCHEMBL6808678 0.81 EPOR (0.69) EPORALOX5PTGS1PTGS2ALOX5AP
SCHEMBL11157827 0.74 EPOR (0.62) EPORALOX5PTGS1PTGS2ALOX5AP
SCHEMBL9359231 0.74 EPOR (0.62) EPORALOX5PTGS1PTGS2ALOX5AP
SCHEMBL30721682 0.74 EPOR (0.62) EPORALOX5PTGS1PTGS2ALOX5AP
SCHEMBL25951367 0.74 ALOX5 (0.60) EPORALOX5PTGS1PTGS2ALOX5AP
SCHEMBL7086903 0.72 ALOX5 (0.66) EPORALOX5PTGS1PTGS2ALOX5AP
SCHEMBL7086909 0.72 ALOX5 (0.66) EPORALOX5PTGS1PTGS2ALOX5AP
SCHEMBL9311190 0.72 GABBR2 (0.43) ALOX5PTGS1PTGS2
SCHEMBL9311202 0.72 GABBR2 (0.43) ALOX5PTGS1PTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040248815-A1 Substituted amino acids as erythropoietin mimetics ORTHO MCNEIL PHARMACEUTICAL, INC. 2004-12-09 US disclosed
US-20020016350-A1 Substituted amino acids as erythropoietin mimetics CONNOLLY PETER J (US) 2002-02-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020016350-A1 Substituted amino acids as erythropoietin mimetics EPOR, EDNRA, FLT1 EPOR 1/4885ALOX5 3840/4885PTGS1 976/4885
US-20040248815-A1 Substituted amino acids as erythropoietin mimetics EPOR, EDNRA, FLT1 EPOR 1/4885ALOX5 3840/4885PTGS1 976/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.